World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
63
Citations
14676
World Ranking
3021
National Ranking
202

Barbara Seliger publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Barbara Seliger sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 266 publications — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Barbara Seliger D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Barbara Seliger sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 63 D-Index — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Barbara Seliger is affiliated with Martin Luther University Halle-Wittenberg in Germany. Their research encompasses a broad range of topics within medicine, with a focus on immunology, oncology, and molecular biology. Their publications contribute to the fields of cancer immunotherapy, immune cell function, and immune responses, with significant work also touching on cancer genomics, diagnostics, and CAR-T cell therapy research.

The scientist has published extensively on topics including:

  • Cancer Immunotherapy and Biomarkers
  • Immune Cell Function and Interaction
  • Immunotherapy and Immune Responses
  • Cancer Genomics and Diagnostics
  • CAR-T cell therapy research
  • MicroRNA in disease regulation
  • Reproductive System and Pregnancy

Seliger has contributed to multiple subfields of study, primarily within:

  • Immunology
  • Oncology
  • Molecular Biology
  • Cancer Research
  • Pulmonary and Respiratory Medicine

In terms of main fields of study, their work covers:

  • Medicine
  • Immunology and Microbiology
  • Biochemistry, Genetics and Molecular Biology

The scientist frequently publishes in a select group of journals and venues, including:

  • Frontiers in Immunology
  • Cancers
  • OncoImmunology
  • Preprints.org
  • Journal for ImmunoTherapy of Cancer

Barbara Seliger's recent significant papers include:

  • "What turns CREB on? And off? And why does it matter?" (2020), Cellular and Molecular Life Sciences
  • "Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer" (2020), Nature Communications
  • "Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity" (2020), Journal for ImmunoTherapy of Cancer
  • ""UniCAR"-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells" (2020), Scientific Reports
  • "Epstein-Barr Virus-Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies" (2021), Cancers

Seliger collaborates frequently with other researchers, including:

  • Claudia Wickenhauser
  • Chiara Massa
  • Marcus Bauer
  • Christoforos Vaxevanis
  • Karthikeyan Subbarayan

Best Publications

  • LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells.

    Almut Brand;Katrin Singer;Gudrun E. Koehl;Marlene Kolitzus

  • Hydrogen peroxide – production, fate and role in redox signaling of tumor cells

    Claudia Lennicke;Jette Rahn;Rudolf Lichtenfels;Ludger A. Wessjohann

  • Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape.

    Leisha A. Emens;Paolo A. Ascierto;Phillip K. Darcy;Sandra Demaria

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  • Dengue Virus Infection of Human Endothelial Cells Leads to Chemokine Production, Complement Activation, and Apoptosis

    Panisadee Avirutnan;Prida Malasit;Barbara Seliger;Sucharit Bhakdi

  • A Critical Requirement of Interferon γ-mediated Angiostasis for Tumor Rejection by CD8+ T Cells

    Zhihai Qin;Johannes Schwartzkopff;Felicia Pradera;Thomas Kammertoens

  • Inhibition of Tumor-Derived Prostaglandin-E2 Blocks the Induction of Myeloid-Derived Suppressor Cells and Recovers Natural Killer Cell Activity

    Yumeng Mao;Dhifaf Sarhan;André Steven;Barbara Seliger

  • Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies?

    Elena Neumann;Arne Engelsberg;Jochen Decker;Stephan Störkel

  • NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis

    Ariella Glasner;Assi Levi;Jonatan Enk;Batya Isaacson

  • Immune signature of tumor infiltrating immune cells in renal cancer

    Katharina Geissler;Paolo Fornara;Christine Lautenschläger;Hans-Jürgen Holzhausen

  • Strategies of Tumor Immune Evasion

    Barbara Seliger

  • What turns CREB on? And off? And why does it matter?

    André Steven;Michael Friedrich;Paul Jank;Nadine Heimer

  • Warburg phenotype in renal cell carcinoma: high expression of glucose-transporter 1 (GLUT-1) correlates with low CD8+ T-cell infiltration in the tumor

    Katrin Singer;Michael Kastenberger;Eva Gottfried;Christine G. Hammerschmied

  • Functional Role of Human Leukocyte Antigen-G Up-Regulation in Renal Cell Carcinoma

    Jürgen Bukur;Vera Rebmann;Hans Grosse-Wilde;Hans Luboldt

  • Multiparametric immune profiling in HPV- oral squamous cell cancer.

    Zipei Feng;Daniel Bethmann;Matthias Kappler;Carmen Ballesteros-Merino

  • AML1-ETO requires enhanced C/D box snoRNA/RNP formation to induce self-renewal and leukaemia

    Fengbiao Zhou;Yi Liu;Yi Liu;Christian Rohde;Christian Rohde;Cornelius Pauli

  • The Role of Immune Escape and Immune Cell Infiltration in Breast Cancer.

    André Steven;Barbara Seliger

  • B7-H4 Expression in Human Melanoma: Its Association with Patients' Survival and Antitumor Immune Response

    Dagmar Quandt;Eckhard Fiedler;Diana Boettcher;Wolfgang Ch Marsch

  • Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis.

    Wouter Hendrickx;Ines Simeone;Samreen Anjum;Younes Mokrab

  • Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation

    Barbara Seliger;Ulrike Ritz;Soldano Ferrone

  • HER-2/neu-mediated regulation of components of the MHC class I antigen-processing pathway.

    Felix Herrmann;Hans-Anton Lehr;Ingo Drexler;Gerd Sutter

Frequent Co-Authors

Rolf Kiessling
Rolf Kiessling Karolinska Institute
Arndt Hartmann
Arndt Hartmann University of Erlangen-Nuremberg
Ludger A. Wessjohann
Ludger A. Wessjohann Leibniz Association
Carsten Denkert
Carsten Denkert Philipp University of Marburg
Soldano Ferrone
Soldano Ferrone Harvard University
Francesco M. Marincola
Francesco M. Marincola National Institutes of Health
Ena Wang
Ena Wang Toro bio
Bernard A. FoxEarle
Bernard A. FoxEarle Earle A. Chiles Research Institute
Ofer Mandelboim
Ofer Mandelboim Hebrew University of Jerusalem
Giuseppe Masucci
Giuseppe Masucci Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens various healthcare career opportunities, especially when combined with nursing qualifications. Many professionals consider transitioning within nursing specialties to enhance their expertise and impact. For example, those looking to deepen their clinical skills can explore the fnp to acnp pathway, which shifts focus towards acute care nursing, a crucial area in immunology-related patient care.

For individuals seeking faster routes into advanced practice nursing, accelerated np program options provide streamlined, flexible education designed for working professionals. These programs help build clinical competencies aligned with immunological healthcare demands.

Non-nurses interested in entering the nursing field to complement their immunology background can find valuable resources by exploring best online bsn programs for non nurses. These programs allow for a smooth transition into nursing and can be pursued fully online.

Additionally, some students opt for the quickest entry through accelerated bsn programs for non nurses, which offer easier admission processes and faster completion times, enabling graduates to launch their healthcare careers without delay.

Best Scientists Citing Barbara Seliger

Trending Scientists

Recently Published Articles